A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

NCT06183216 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infectious Disease

Interventions

BIOLOGICAL: Sinovac PCV13
BIOLOGICAL: PREVNAR 13

Sponsor

Sinovac Research and Development Co., Ltd.